@article{IR, author = {Singh, Prem and Demessie, Ananiya A. and Park, Youngrong and Moses, Abraham S. and Korzun, Tetiana and Sabei, Fahad Y. and Albarqi, Hassan A. and Campos, Leonardo and Wyatt, Cory R. and Farsad, Khashayar and Dhagat, Pallavi and Sun, Conroy and Taratula, Olena "Oleh" R.}, url = {http://digitalcollections.ohsu.edu/record/41877}, title = {An advanced thermal decomposition method for the synthesis of novel cobalt-doped core (magnetite) – shell (maghemite) iron oxide nanoparticles with ultrahigh heating efficiency for systemic magnetic hyperthermia}, publisher = {Oregon Health and Science University}, abstract = {Owing to the low heating efficiency of currently available magnetic nanoparticles, it is challenging to reach therapeutic temperatures above 44 0C in tumors that are generally difficult to access after systemic delivery of nanoparticles at clinical dosage (10 mg kg-1). In order to solve this problem, we have developed an advanced thermal decomposition method for the synthesis of novel cobalt-doped core (magnetite) – shell (maghemite) iron oxide nanoparticles (Co-Fe3O4/γ-Fe2O3) with an ultrahigh ILP of 48.0 nH m2 kg-1. Our in vivo research shows that these nanoparticles containing a cancer-targeting peptide are biocompatible and accumulate well in ovarian cancer grafts after being administered systemically at a concentration of 4 mg kg-1. When exposed to an external AMF (420 kHz, 26.9 kA m-1), the delivered nanoparticles elevate temperature in both subcutaneous and metastatic cancer tumors to 50 0C. This newly developed synthesis method can be used for the synthesis of both non-doped core-shell nanoparticles and core-shell nanoparticles doped with different metals (e.g., Ni, Co). As a result, this strategy could be extended to the development of novel nanoparticles with even greater heating performance, further advancing systemic magnetic hyperthermia for cancer treatment.}, number = {IR}, doi = {https://doi.org/10.6083/bpxhc41877}, recid = {41877}, address = {2023-09-11}, }